A printable hydrogel microarray for drug screening avoids false positives associated with promiscuous aggregating inhibitors
False positive results significantly slow down the drug discovery process. Here, the authors developed a gel serving as a screening platform in which enzymes can be stored, stabilized, and protected from most of the compounds that typically cause these misleading results.
Guardado en:
Autores principales: | Rabia Mateen, M. Monsur Ali, Todd Hoare |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2018
|
Materias: | |
Acceso en línea: | https://doaj.org/article/b15875df484545e4be2b90b2fc1c4eda |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Printable homocomposite hydrogels with synergistically reinforced molecular-colloidal networks
por: Austin H. Williams, et al.
Publicado: (2021) -
Screening participation after a false positive result in organized cervical cancer screening: a nationwide register-based cohort study
por: Pernille Thordal Larsen, et al.
Publicado: (2020) -
Target position and avoidance margin effects on path planning in obstacle avoidance
por: Mohammad R. Saeedpour-Parizi, et al.
Publicado: (2021) -
Identification and elimination of false positives in electrochemical nitrogen reduction studies
por: Jaecheol Choi, et al.
Publicado: (2020) -
Structure-based evolution of a promiscuous inhibitor to a selective stabilizer of protein–protein interactions
por: Eline Sijbesma, et al.
Publicado: (2020)